{"schema_version":"secwatch.filing_event.v1","accession":"0001651944-24-000031","form_type":"8-K","ticker":null,"cik":"0001651944","company_name":"DermTech, Inc.","filed_at":"2024-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.436399+00:00","generated_at":"2026-06-03T18:58:17.267534+00:00","sec_items":["2.05","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"DermTech cuts 56% of workforce, explores strategic alternatives including sale","bullets":["Board approved restructuring: reduce workforce by ~100 employees (56% of staff); expects $1.6M charge in Q2 2024.","Special committee engaged TD Cowen to explore strategic alternatives: acquisition, merger, reverse merger, asset sale.","Engaged AlixPartners as restructuring advisor; will not hold Q1 2024 earnings call.","Intends to continue laboratory operations during review; sufficient capacity for DMT test."],"urls":{"canonical":"https://secwatch.observer/filing/0001651944-24-000031","json":"https://secwatch.observer/filing/0001651944-24-000031.json","markdown":"https://secwatch.observer/filing/0001651944-24-000031.md","text":"https://secwatch.observer/filing/0001651944-24-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651944/000165194424000031/0001651944-24-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651944/000165194424000031/dmtk-20240418.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T18:58:17.267534+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a231509c606953cdc567ba83af1f99d3bcd4edf","claim":"DermTech, Inc. announced a restructuring with charges of approximately $1.6 million (approximately 100 employees).","evidence_excerpt":"The restructuring plan will include a reduction of its current workforce by approximately 100 employees, or approximately 56% of the Company’s workforce. The Company estimates that it will incur aggregate pre-tax charges of approximately $1.6 million in connection with the Reduction in Force, primarily consisting of severance payments, employee benefits, outplacement services and related costs.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1651944/000165194424000031/0001651944-24-000031-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $1.6 million"},{"label":"Headcount","value":"approximately 100 employees"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}